Novel Therapies in APOL1-Mediated Kidney Disease: From Molecular Pathways to Therapeutic Options
Author:
Publisher
Elsevier BV
Subject
Nephrology
Reference86 articles.
1. Association of trypanolytic ApoL1 variants with kidney disease in African Americans;Genovese;Science,2010
2. Worldwide frequencies of APOL1 renal risk variants;Nadkarni;N Engl J Med,2018
3. Population-based risk assessment of APOL1 on renal disease;Friedman;J Am Soc Nephrol,2011
4. APOL1 variants associate with increased risk of CKD among African Americans;Foster;J Am Soc Nephrol,2013
5. Phenome-wide association analysis suggests the APOL1 linked disease spectrum primarily drives kidney-specific pathways;Bajaj;Kidney Int,2020
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Differing sensitivities to angiotensin converting enzyme inhibition of kidney disease mediated by APOL1 high-risk variants G1 and G2;Kidney International;2024-08
2. Cardiac and Renal Comorbidities in Aging People Living With HIV;Circulation Research;2024-05-24
3. Progression of chronic kidney disease among adults attending tertiary hospitals in Dodoma, Tanzania;2024-04-04
4. Advances in the management of chronic kidney disease – a South African perspective;Wits Journal of Clinical Medicine;2024
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3